Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MGLL | Q99685 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.35 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14658329 | 1.00 | ALDH1A1 (0.43) | ALDH1A1MGLLHPGDSMN1; SMN2TSHR | |
| SCHEMBL1155762 | 0.73 | CYP2A6 (0.38) | ALDH1A1TSHRACHEMEN1KMT2A | |
| SCHEMBL1005413 | 0.70 | ADRB1 (0.48) | ALDH1A1MGLLHPGDSMN1; SMN2TSHR | |
| SCHEMBL10983420 | 0.69 | MGLL (0.62) | ALDH1A1MGLLHPGDSMN1; SMN2TSHR | |
| SCHEMBL6678527 | 0.68 | POLB (0.46) | ALDH1A1HPGDTSHRMEN1KMT2A | |
| SCHEMBL22430823 | 0.67 | ALDH1A1 (0.43) | ALDH1A1MGLLHPGDSMN1; SMN2TSHR | |
| SCHEMBL1156328 | 0.67 | ALDH1A1 (0.48) | ALDH1A1MGLLHPGDSMN1; SMN2TSHR | |
| Hydrochloric Acid SCHEMBL1155766 | 0.65 | ALDH1A1 (0.47) | ALDH1A1MGLLHPGDSMN1; SMN2TSHR | |
| SCHEMBL19725777 | 0.65 | ALDH1A1 (0.42) | ALDH1A1MGLLHPGDSMN1; SMN2TSHR | |
| SCHEMBL1126941 | 0.65 | CYP1A2 (0.61) | ALDH1A1MGLLHPGDSMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2826802-B1 | METHOD FOR PRODUCING RING-OPENING METATHESIS POLYMER HYDRIDE, AND RESIN COMPOSITION | ZEON CORP (JP) | 2021-03-10 | — | — | EP | disclosed |
| US-20180127520-A1 | METHOD FOR PRODUCING RING-OPENING METATHESIS POLYMER HYDRIDE, AND RESIN COMPOSITION | ZEON CORPORATION (JP) | 2018-05-10 | — | — | US | disclosed |
| EP-2739653-B1 | METHODS OF POLYMERIZING SILANES AND CYCLOSILANES USING N-HETEROCYCLIC CARBENES AND METAL COMPLEXES HAVING N-HETEROCYCLIC CARBENE LIGANDS | THIN FILM ELECTRONICS ASA (NO) | 2018-01-10 | — | — | EP | disclosed |
| US-9850325-B2 | Method for producing ring-opening metathesis polymer hydride, and resin composition | ZEON CORPORATION (JP) | 2017-12-26 | — | — | US | disclosed |
| EP-1534722-B1 | RHODIUM AND IRIDIUM COMPLEXES | MERCK PATENT GMBH (DE) | 2017-03-22 | — | — | EP | disclosed |
| EP-2270063-B1 | PROCESS FOR PRODUCING HYDROGENATED PRODUCT OF CYCLIC OLEFIN POLYMER PREPARED THROUGH RING-OPENING POLYMERIZATION | ZEON CORP (JP) | 2016-03-23 | — | — | EP | disclosed |
| US-20150051353-A1 | METHOD FOR PRODUCING RING-OPENING METATHESIS POLYMER HYDRIDE, AND RESIN COMPOSITION | ZEON CORPORATION (JP) | 2015-02-19 | — | — | US | disclosed |
| EP-2826802-A1 | METHOD FOR PRODUCING RING-OPENING METATHESIS POLYMER HYDRIDE, AND RESIN COMPOSITION | Zeon Corporation (JP) | 2015-01-21 | — | — | EP | disclosed |
| US-8900654-B2 | Methods of polymerizing silanes and cyclosilanes using N-heterocyclic carbenes, metal complexes having N-heterocyclic carbene ligands, and lanthanide compounds | Thin Film Electronics, Inc. (NO) | 2014-12-02 | — | — | US | disclosed |
| EP-2289902-B1 | Rhodium and iridium complexes | MERCK PATENT GMBH (DE) | 2014-04-30 | — | — | EP | disclosed |
| EP-1275675-B1 | COPOLYMER FORMED BY RING-OPENING POLYMERIZATION, PRODUCT OF HYDROGENATION OF COPOLYMER FORMED BY RING-OPENING POLYMERIZATION, AND PROCESSES FOR PRODUCING THESE | ZEON CORP (JP) | 2005-12-07 | — | — | EP | disclosed |
| US-6908970-B2 | Process for producing hydrogenated product of cyclic olefin polymer prepared through ring-opening polymerization | ZEON CORPORATION (JP) | 2005-06-21 | — | — | US | disclosed |
| EP-1379534-B1 | RHODIUM AND IRIDIUM COMPLEXES | COVION ORGANIC SEMICONDUCTORS (DE) | 2004-12-15 | — | — | EP | disclosed |
| US-6815516-B2 | HEAT RESISTANCE, SOLVENT SOLUBILITY | ZEON CORPORATION (JP) | 2004-11-09 | — | — | US | disclosed |
| US-20040133004-A1 | Rhodium and iridium complexes | MERCK PATENT GMBH (DE) | 2004-07-08 | — | — | US | disclosed |
| US-20030050406-A1 | Process for producing hydrogenated product of cyclic olefin polymer prepared through ring-opening polymerization | ZEON CORPORATION | 2003-03-13 | — | — | US | disclosed |
| US-20030018138-A1 | Copolymer formed by ring -opening polymerization, product of hydrogenation of copolymer formed by ring-opening polymerization, and process for producing these | ZEON CORPORATION (JP) | 2003-01-23 | — | — | US | disclosed |
| EP-1275675-A1 | COPOLYMER FORMED BY RING-OPENING POLYMERIZATION, PRODUCT OF HYDROGENATION OF COPOLYMER FORMED BY RING-OPENING POLYMERIZATION, AND PROCESSES FOR PRODUCING THESE | Zeon Corporation (JP) | 2003-01-15 | — | — | EP | disclosed |
| US-6486264-B1 | Process for producing hydrogenated ring-opening polymerization polymer of cycloolefin | ZEON CORPORATION (JP) | 2002-11-26 | — | — | US | disclosed |
| EP-1197509-A1 | PROCESS FOR PRODUCING HYDROGENATED RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN | Nippon Zeon Co., Ltd. (JP) | 2002-04-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040133004-A1 | Rhodium and iridium complexes | RPIA, SIRT5, INPP5B | ALDH1A1 1115/4885MGLL 3290/4885HPGD 1987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.